Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Tuberculosis


Other Names for this Disease
  • Kochs disease
  • TB
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Tuberculosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Aminosalicylic acid
Trade Name
(Manufacturer Name)
Paser Granules
(Jacobus Pharmaceutical Company)
Indication
The FDA has approved this product to be used in this manner.
Treatment of tuberculosis
More Information about this product Drug Information Portal

Generic Name Rifapentine
Trade Name
(Manufacturer Name)
Priftin®
(Sanofi Aventis)
Indication
The FDA has approved this product to be used in this manner.
Treatment of pulmonary tuberculosis.
More Information about this product Drug Information Portal

Generic Name Rifampin
Trade Name
(Manufacturer Name)
Rifadin I.V.®
(Sanofi Aventis)
Indication
The FDA has approved this product to be used in this manner.
For antituberculosis treatment where use of the oral form of the drug is not feasible.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Rifampin, isoniazid, pyrazinamide
Trade Name
(Manufacturer Name)
Rifater®
(Sanofi Aventis)
Indication
The FDA has approved this product to be used in this manner.
Short-course treatment of tuberculosis.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Bedaquiline
Trade Name
(Manufacturer Name)
Sirturo
(Janssen Research & Development, LLC)
Indication
The FDA has approved this product to be used in this manner.
Part of combination therapy in adults (greater than or equal to 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB).
More Information about this product Drug Information Portal